Comparing Laboratory Corp. of America (LH) and CorVel (CRVL)
Laboratory Corp. of America (NYSE: LH) and CorVel (NASDAQ:CRVL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.
Volatility and Risk
Laboratory Corp. of America has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, CorVel has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500.
This table compares Laboratory Corp. of America and CorVel’s revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Laboratory Corp. of America||$10.44 billion||1.68||$1.27 billion||$12.21||14.11|
|CorVel||$518.69 million||1.76||$29.47 million||$1.82||26.62|
Laboratory Corp. of America has higher revenue and earnings than CorVel. Laboratory Corp. of America is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.
This table compares Laboratory Corp. of America and CorVel’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Laboratory Corp. of America||12.15%||16.30%||6.38%|
This is a breakdown of current recommendations for Laboratory Corp. of America and CorVel, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Laboratory Corp. of America||0||5||9||1||2.73|
Laboratory Corp. of America currently has a consensus target price of $187.36, indicating a potential upside of 8.78%. Given Laboratory Corp. of America’s higher possible upside, research analysts plainly believe Laboratory Corp. of America is more favorable than CorVel.
Institutional and Insider Ownership
90.4% of Laboratory Corp. of America shares are held by institutional investors. Comparatively, 43.6% of CorVel shares are held by institutional investors. 0.9% of Laboratory Corp. of America shares are held by company insiders. Comparatively, 51.0% of CorVel shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Laboratory Corp. of America beats CorVel on 9 of the 14 factors compared between the two stocks.
Laboratory Corp. of America Company Profile
Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.
CorVel Company Profile
CorVel Corporation (Corvel) is a provider of workers’ compensation solutions for employers, third party administrators, insurance companies and government agencies. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company offers its services as a bundled solution, which includes claims management, as a standalone service, or as add-on services to existing customers. The Company’s network solutions include bill review, preferred provider organization (PPO) management, professional review, provider reimbursement, pharmacy services, directed care services, medicare solutions and clearinghouse services. The Company’s patient management services include claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, life care planning, disability management, liability claims management and auto claims management.
Receive News & Ratings for Laboratory Corp. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corp. of America and related companies with MarketBeat.com's FREE daily email newsletter.